戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mobilization and controlled released of beta-galactosidase.
2 nzymatic hydrolisis by Escherichia coli beta-galactosidase.
3 ymatic assays confirmed its activity of beta-galactosidase.
4 eptococcus, a bacterial surface-exposed beta-galactosidase.
5  at 95% lactose depletion for K. lactis beta-galactosidase.
6 lective artificial protein receptor for beta-galactosidase.
7  a prodrug converted into Daunorubicin by ss-galactosidase.
8 ry beta-lactoglobulin but too small for beta-galactosidase.
9 only exons 1-4 were expressed, fused to beta-galactosidase.
10 rference with the enzymatic activity of beta-galactosidase.
11 ity-based probes that target retaining alpha-galactosidases.
12 inetic binding studies with substituted beta-galactosidases.
13 erization is not a universal feature of beta-galactosidases.
14 support for the immobilization of model beta-galactosidases.
15 idase 1 (Neu1), neuraminidase 3 (Neu3), beta-galactosidase 1 (Glb1), and hexosaminidase B (HexB), pos
16 ly, no method is available to identify alpha-galactosidase A (agalA) mutations determining clinically
17 d lysosomal storage disorder caused by alpha-galactosidase A (alpha-GAL A) deficiency.
18                  Clinical assessments, alpha-galactosidase A (alpha-GalA) activities, glycosphingolip
19 neumoniae mutants deficient in NanA and beta-galactosidase A (BgaA) failed to form biofilms in vivo d
20  A gene knockout (Gla KO) mice have no alpha-galactosidase A activity and progressively accumulate GL
21 ype observed in patients with residual alpha-galactosidase A activity.
22 ase is caused by deficient activity of alpha-galactosidase A and subsequent accumulation of glycosphi
23 isease caused by deficient activity of alpha-galactosidase A and the resultant systemic accumulation
24 torage disorder caused by a deficit in alpha-galactosidase A enzyme activity leading to glycosphingol
25                              Leukocyte alpha-galactosidase A enzyme activity was mildly reduced in 19
26  caused by the absence or reduction of alpha-galactosidase A enzyme activity.
27                                        alpha-Galactosidase A gene knockout (Gla KO) mice have no alph
28  of the N215S (c.644A>G [p.Asn215Ser]) alpha-galactosidase A gene variant.
29     We studied whether cardio-specific alpha-galactosidase A gene variants are misinterpreted as hype
30 inked Fabry disease (FD) caused by GLA(alpha-galactosidase A gene) mutations encoding p.D322E (family
31                                        alpha-Galactosidase A genotype N215S does not lead to the deve
32 orage disorder caused by deficiency of alpha-galactosidase A, resulting in glycosphingolipid accumula
33 r caused by a deficiency of the enzyme alpha-galactosidase A, which results in the progressive accumu
34 mulation and deletion of iNKT cells in alpha-galactosidase A-deficient (alphaGalA(-/-)) mice (human F
35 b3Cer) in the kidneys of wild-type and alpha-galactosidase A-knockout (Fabry) mice was possible at ab
36 se, which is caused by a deficiency in alpha-galactosidase A.
37 deficient activity of lysosomal enzyme alpha-galactosidase A.
38 increases in senescence associated (SA) beta-galactosidase, a known marker of cellular senescence.
39                                         beta-galactosidase, a lysosomal protein, was elevated 3.6-5.7
40 en fluorescent protein (GFP)-AAP2BR and beta-galactosidase-AAP2BR fusion proteins, respectively, and
41         X-gal analysis has shown strong beta-galactosidase activities in the prostate, brain, and few
42 ere imaged with and without a stain for beta-galactosidase activity (S-Gal + ferric ammonium citrate)
43                      We also found high beta-galactosidase activity accompanying tension wood differe
44 he gene responsible for the majority of beta-galactosidase activity against xyloglucan.
45  the induction of senescence-associated beta-galactosidase activity and cell morphology.
46                             Analysis of beta-galactosidase activity and controlled release reveals th
47  the induction of senescence-associated beta-galactosidase activity and flat cell morphology.
48 by an increase in senescence-associated beta-galactosidase activity and formation of senescence-assoc
49 s effectively demonstrated in vitro for beta-galactosidase activity and in vivo in a mouse model of i
50 totic but displayed senescence associated-ss-galactosidase activity and upregulated p16, indicating p
51 spectively, which by their lacZ encoded beta-galactosidase activity convert the inactive prodrug Daun
52 rmination of the fusion protein via its beta-galactosidase activity found 8.3 and 9.8 ng/mug (nanogra
53 porter assay linking LasR function with beta-galactosidase activity gave results consistent with thos
54 taGal sensitively detects intracellular beta-galactosidase activity in several ovarian cancer lines.
55  in Escherichia coli yields significant beta-galactosidase activity in vivo from a lacZ gene containi
56             Some cerebral LLC exhibited beta galactosidase activity indicating a senescence phenotype
57 e was assessed as senescence-associated beta-galactosidase activity using flow cytometry, oxidative s
58                                         beta-Galactosidase activity was detected in osteocytes of sos
59 e senescence, as indicated by increased beta-galactosidase activity, elevated CDKN1A mRNA expression,
60 ined by a rise in senescence-associated beta-galactosidase activity, higher abundance of CDKN1A/P21 a
61 splayed increased senescence-associated beta-galactosidase activity, lower average telomere lengths b
62 induced increased senescence-associated beta-galactosidase activity, oxidative stress, early phosphor
63 arkers (increased senescence associated-beta galactosidase activity, p16, and p53 expression and lowe
64 ed with decreased senescence-associated beta-galactosidase activity, preserved telomere length, reduc
65 erative capacity, senescence-associated beta-galactosidase activity, the known senescence-inducing pa
66 e, as assessed by senescence-associated beta-galactosidase activity, was induced by the passaging of
67 sing the novel phenotype of periplasmic beta-galactosidase activity, we show that the periplasmic cha
68 ll morphology and senescence-associated beta-galactosidase activity.
69 y become senescent, as determined by SA-beta-galactosidase activity.
70 est and increased senescence-associated beta-galactosidase activity.
71 cence and express senescence-associated beta-galactosidase activity.
72 equence caused an 8.6-fold reduction in beta-galactosidase activity.
73    Cellular senescence was monitored by beta-galactosidase activity.
74 criptional fusion norA-lacZ for altered beta-galactosidase activity.
75 gy, and increased senescence-associated beta-galactosidase activity.
76 oviruses (genogroup III) interact with alpha-galactosidase (alpha-Gal) carbohydrates, and murine noro
77 s possibly involved in apple softening, beta-galactosidase, alpha-arabinofuranosidase, polygalacturon
78  and 4 inhibit the two human retaining alpha-galactosidases alphaGal A and alphaGal B covalently and
79                                         beta-Galactosidase also exhibited glycoproteineous properties
80 0 xyl1 double mutant, deficient in both beta-galactosidase and alpha-xylosidase.
81 cts of ganglioside hydrolases, e.g., of beta-galactosidase and beta-hexosaminidases, and of GM2-activ
82 an only be detected and qualified after beta-galactosidase and beta-N-acetylhexosaminidase digestion.
83                                         beta-Galactosidase and beta-N-acetylhexosaminidase were used
84 needle-mediated intradermal delivery of beta-galactosidase and formaldehyde-inactivated botulinum tox
85  exposure and hydrolysis by exoglycosidases (galactosidase and hexosaminidase).
86 -ON probes for detection and imaging of beta-galactosidase and hydrogen peroxide.
87 e markers, namely senescence-associated beta-galactosidase and increased p16(INK4a)/p19(ARF) expressi
88 en shown to restore activity of mutant alpha-galactosidase and is currently in clinical trial for tre
89   We studied the enzymatic reaction for beta-galactosidase and its substrate (resorufin-beta-D-galact
90 increased senescence-associated markers beta-galactosidase and p16 mRNA in aged CPCs.
91 e of a complex between Escherichia coli beta-galactosidase and the cell-permeant inhibitor phenylethy
92 nzymatic activity of the cargo proteins beta-galactosidase and the enzymatic subunit of Clostridium b
93 onstrated with the accurate modeling of beta-galactosidase and TRPV1 proteins at 3.2 A and 3.4 A reso
94 en labeled with an enzyme (streptavidin-beta-galactosidase), and single enzymes associated with these
95  hexosaminidase, galactosylceramidase, alpha-galactosidase, and beta-galactosidase) mediating glycosp
96 vered intracistronic complementation in beta-galactosidase, and investigated the role of cAMP in Esch
97 luding p16, EGFP, senescence-associated beta-galactosidase, and the senescence-associated secretory p
98  40-50% with B. circulans and A. oryzae beta-galactosidases, and at 95% lactose depletion for K. lact
99 e a fluctuation type of distribution of beta-galactosidase appearance in a growing culture, consisten
100  hydrolysis of RFOs increase the Cicer alpha-galactosidase application in food processing industries.
101  solution structure of Escherichia coli beta-galactosidase ( approximately 465 kDa), solved at approx
102 panies the use of senescence-associated beta-galactosidase as a collection of semiselective markers t
103 ed with adenoviruses containing A20 (or beta-galactosidase as a control) were allografted into major
104 ssful intracellular delivery of bioactive ss-galactosidase as a model enzyme was also demonstrated us
105                                   Using beta-galactosidase as a reporter for the null gene, developme
106 nhibition of the hydrolytic activity of beta-galactosidase (Aspergillus oryzae) was evaluated.
107  we established a senescence associated beta-galactosidase assay as a screening platform to rapidly i
108 d dramatically the dynamic range of the beta-galactosidase assay for cadBA activation.
109  staining reaction than the traditional beta-galactosidase assay in mouse embryos.
110        Using Northern hybridization and beta-galactosidase assays of an ace promoter-lacZ fusion, we
111  cytotoxicity and senescence-associated beta-galactosidase assays, which were compared with dissolved
112 osomal enzymes (alpha-glucosidase (AG), beta-galactosidase (B-GAL) and beta-N-acetylglucosamidase (B-
113 uring treatment with several commercial beta-galactosidases (Bacillus circulans, Kluyveromyces lactis
114 ant was also 'leaking' as revealed by a beta-galactosidase-based assay employing a membrane impermeab
115 pithelial cells (PI-MECs)-are marked by beta-galactosidase (beta Gal) expression following pregnancy
116 the DeltabioR DeltabioBFDA mutant), the beta-galactosidase (beta-Gal) activity of three plasmid-borne
117 h amounts of galactose and considerable beta-galactosidase (beta-Gal) activity was observed.
118                                         beta-galactosidase (beta-gal) and beta-glucuronidase (beta-gl
119 was implemented into the procedure with beta-galactosidase (beta-gal) as the detection enzyme.
120 iated lysis was used to release endemic beta-galactosidase (beta-gal) from the bound bacterial cells;
121          In these animals, staining for beta-galactosidase (beta-gal) identifies cells in which NF-ka
122                We demonstrate that when beta-galactosidase (beta-gal) is expressed in LECs, beta-gal-
123 k, specific immobilization of 6-phospho-beta-galactosidase (beta-Gal) on a self-assembled monolayer (
124 es, namely pectin methylesterase (PME), beta-galactosidase (beta-Gal), endo-1,4-beta-D-glucanase (EGa
125 mbinant A20 adenovirus (rAd.A20) or rAd.beta-galactosidase (beta-gal), implanted, harvested 4 weeks a
126 12, which expresses the omega-domain of beta-galactosidase (beta-gal).
127 ngineered with lacZ operon encoding for beta-galactosidase (beta-gal).
128 mes resulted in increased expression of beta-galactosidase(beta-gal) plasmid in rat brain tissue in c
129 osidase/beta-xylosidase that also shows beta-galactosidase, beta-fucosidase, alpha-arabinofuranosidas
130  reduction or absence of lysosomal acid beta-galactosidase (betagal) activity.
131                                   Using beta-galactosidase (betagal) as a model system, we have emplo
132 to cell fate reporter mice that express beta-galactosidase (betagal) in cells of AEC lineage.
133                         Mice expressing beta-galactosidase (betagal) on a retina-specific promoter (b
134 ew model of memory inflation based on a beta-galactosidase (betagal)-recombinant adenovirus vector.
135 ides 7a-e and 8 were found to be modest beta-galactosidase (bGal) inhibitors.
136                    Galectin-9 (Gal9), a beta-galactosidase-binding protein expressed by T-regs, is ke
137 ses, BoMan26A and BoMan26B, and a GH36 alpha-galactosidase, BoGal36A.
138 xhibit trans-alpha-xylosidase and trans-beta-galactosidase (but not trans-alpha-fucosidase) activitie
139 ent analytes (Pd(0/2+), H(2)O(2), F(-), beta-galactosidase) can be created from the same core structu
140 elastin-binding protein/spliced form of beta-galactosidase chaperone, enhancing secretion.
141 e tit1+ and tit1-Delta cells by using a beta-galactosidase codon-swap reporter whose catalytic activi
142          In the current study we used a beta-galactosidase complementation method to screen a selecti
143                               We used a beta-galactosidase complementation method to screen several t
144  PCR assay to detect NWM SFV DNA, and a beta-galactosidase-containing indicator cell line to assay re
145                       Importantly, endo-beta-galactosidase coupled with MALDI-MS allowed these two ep
146 ith LC-MS/MS, indicating that Chick pea beta-galactosidase (CpGAL) is a heterodimer.
147 ase, an X-linked disorder of lysosomal alpha-galactosidase deficiency, leads to substrate accumulatio
148 ansport of a model therapeutic enzyme (alpha-galactosidase, deficient in lysosomal Fabry disease).
149 ies provide an enhanced alternative for beta-galactosidase detection in expression and cell fate stud
150 cheal delivery of AAV1 was confirmed by beta-galactosidase detection in the distal pulmonary vasculat
151  gene and lacz reporter cDNA coding for beta-galactosidase directed by the CerS6 promoter.
152 ein G domain but delays that of a large beta-galactosidase domain as a result of kinetic trapping of
153                                         beta-Galactosidase, encoded by lacZ, is usually detected usin
154 l of oligonucleotides to the surface of beta-galactosidase enhances its cellular uptake of by up to a
155 Monastrell wines were also treated with beta-galactosidase enzyme addition and commercial enzyme addi
156 ques (cold pre-fermentative maceration, beta-galactosidase enzyme addition and enzymatic preparation
157 d by hydrolyzing native guar gum using alpha-galactosidase enzyme.
158                                         beta-Galactosidase enzymes are used in the dairy industry to
159 genic AlbuminCreXRosa26 mice expressing beta-galactosidase exclusively in hepatocytes.
160 nic green fluorescence protein (GFP) or beta-galactosidase expressed from the ROSA26 locus was used t
161                                         beta-galactosidase expression was predominantly found in mous
162 istinct profile of senescence including beta-galactosidase expression, autofluorescence, growth inhib
163 ting in decreased senescence-associated beta-galactosidase expression, increased self-renewal potenti
164 vasive imaging of Hmox1 expression, and beta-galactosidase for high-resolution mapping of expression
165 t 50 of the 67 participants had mutant alpha-galactosidase forms suitable for targeting by migalastat
166            The initial assay of mutant alpha-galactosidase forms that we used to categorize 67 patien
167 andomly assigned patients (with mutant alpha-galactosidase forms that were suitable or not suitable f
168 alysis, involving patients with mutant alpha-galactosidase forms that were suitable or not suitable f
169                            The level of beta-galactosidase from a gerA-lacZ fusion in superdormant sp
170 hia coli l-arabinose promoter and bgaB (beta-galactosidase from Bacillus stearothermophilus) to creat
171  (putrescine transaminase) activity and beta-galactosidase from cells with patA-lacZ transcriptional
172 ageously used to optimally immobilise a beta-galactosidase from chick pea onto alkylamine glass using
173                                       A beta-galactosidase from Cicer arietinum seeds has been purifi
174 ctans from acacia gum by a galactan-beta-1,3-galactosidase from family GH43; however, while B. thetai
175                       Solubilisation of beta-galactosidase from Kluyveromyces lactis in Aerosol-OT wa
176 ese results indicate that (i) levels of beta-galactosidase from lacZ fusions to operons encoding germ
177                       The separation of beta-galactosidase from the test protein beta-lactoglobulin w
178 ifferent GOS profiles of the commercial beta-galactosidases from Bacillus circulans, Kluyveromyces la
179 alCer-beta-galactosylceramidase and GM1-beta-galactosidase functions in the degradation of lactosylce
180                Expression of the kazrin-beta-galactosidase fusion protein faithfully reported endogen
181  using six cryo-EM structures of TRPV1, beta-galactosidase, gamma-secretase, ribosome-EF-Tu complex,
182 as able to image cells transfected with beta-galactosidase gene by chemiluminescence microscopy.
183 type RIMD2210633 strain marked with the beta-galactosidase gene lacZ (WBWlacZ), the mutant colonized
184  rpoE mutant and the WT marked with the beta-galactosidase gene lacZ (WBWlacZ), the mutant strain was
185 arahaemolyticus strains marked with the beta-galactosidase gene lacZ demonstrated that the DeltatoxRS
186 either the BMP inhibitor noggin or the beta- galactosidase gene under the control of a BMP-responsive
187 of the human coagulation factor IX and alpha-galactosidase genes into endogenous genomic loci with hi
188 n (Psap), Niemann Pick type C2 (Npc2), alpha-galactosidase (Gla), are up-regulated in early adipogene
189 is approach (0.5L) using the commercial beta-galactosidase Godo-YNL2.
190                                        alpha-galactosidase has been shown to reduce gas production an
191 livery to the mouse brain of functional beta-galactosidase, human IgG and IgM, and two antibodies tha
192                            Transport of beta-galactosidase, IgG, IgM, and antibodies against amyloid
193 ructures confirmed the utility of a beta-1,3-galactosidase in Bifidobacterium longum subsp. infantis
194 orm, we could investigate the levels of beta-galactosidase in cells grown under different nutrient co
195 y induce expression of Fgfr2(S252W) and beta-galactosidase in either the neural crest or mesoderm of
196  were able to visualize the activity of beta-galactosidase in embryos at stages when the customary X-
197 se factors on the performance of enzyme beta-galactosidase in formulations for reduction of levels of
198 eling in Pw1(nLacZ+/-) mouse expressing beta-galactosidase in PW1(+) cells and in differentiated cell
199  The distribution of neurons expressing beta-galactosidase in the brain and the relative intensity of
200 luate the efficacy and tolerability of alpha-galactosidase in the treatment of gas-related symptoms i
201 ion of the endogenous activity of both alpha-galactosidases in cell extracts, thereby providing a mea
202 infect and express transgenes (hGM-CSF, beta-galactosidase) in tumor-associated vascular endothelial
203 e, stabilizes specific mutant forms of alpha-galactosidase, increasing enzyme trafficking to lysosome
204 f treated cells also stain positive for beta-galactosidase, indicating senescence.
205 ounds, 4-epi-fagomine (2b) was the best beta-galactosidase inhibitor, and it also prevented LPS-media
206 d using gene targeted mice with nuclear beta-galactosidase inserted into the Islet-1 locus.
207 ose-free food and controlled release of beta-galactosidase into lactose-intolerant individuals.
208                                       beta-d-Galactosidase is an important enzyme in the dairy indust
209 a genetic circuit in which synthesis of beta-galactosidase is under control of the arsenite-derepress
210 ide and a constant amount of the enzyme beta-galactosidase, is produced at frequencies in excess of 1
211 n (EBP), a spliced variant of lysosomal beta-galactosidase, is the primary receptor of elastin peptid
212 ein G, ovalbumin, bovine serum albumin, beta-galactosidase, lactoferrin) on the EIG with initial capt
213 ostin (sost) gene was replaced by the beta-D-galactosidase (lacZ) gene in the germ line.
214                                         beta-Galactosidase (lacZ) has bifunctional activity.
215                   Using mice expressing beta-galactosidase (lacZ) under the control of seven repeated
216  completely account for the increase in beta-galactosidase levels in mutT lacZamber cultures, without
217 cts, elevation of senescence-associated beta-galactosidase levels, and changes in gene expression clo
218 pe IV collagen was investigated, but no beta-galactosidase-like activity capable of collagen modifica
219 , accumulated the senescence-associated beta-galactosidase marker, and increased P16 protein expressi
220  positive for the senescence-associated beta-galactosidase marker, suggesting that cells have lost th
221 sylceramidase, alpha-galactosidase, and beta-galactosidase) mediating glycosphingolipid hydrolysis we
222  function observed for the more severe alpha-galactosidase mutants could be enhanced by combining pha
223 ely affected by protein aggregation of alpha-galactosidase mutants, revealing a qualitative differenc
224 domized to receive placebo (n = 25) or alpha-galactosidase (n = 27).
225 examined STOML1 null mutant mice with a beta-galactosidase-neomycin cassette gene-trap reporter drive
226 nctional vascular graft by immobilization of galactosidase on the graft surface.
227 arly, pretreating neutrophils with endo-beta-galactosidase or neuraminidase converted ANCA assay resu
228 ts treated with a control AAV1 carrying beta-galactosidase or saline.
229 on with rats administered AAV1 carrying beta-galactosidase or saline.
230 etected in immune cells of C57BL/6, BRE-beta-galactosidase, or BMP-4(betagal/+) mice.
231 hibit an elevated VEGF, localization of beta-galactosidase outside the subventricular zone (SVZ), sub
232  shows that the glucose binding site of beta-galactosidase played an important role in lac operon evo
233  reduced telomerase activity, increased beta-galactosidase-positive cells, upregulation of the senesc
234 sed the number of senescence-associated beta-galactosidase-positive HSCs and decreased alpha-smooth m
235 hese mice resulted in the generation of beta-galactosidase-positive liver progenitor cells, demonstra
236 lactulose was performed with commercial beta-galactosidase preparations from Aspergillus oryzae, Kluy
237                                         beta-Galactosidase promotes the isomerization by means of an
238 t with the deglycosylating enzyme, endo-beta-galactosidase, reduced the mass of neutrophil hLAMP-2 to
239 AR2 and PDI1 mRNAs, and expression of a beta-galactosidase reporter activated by Hac1(i) Phosphorylat
240 t mice overexpressing human HB-EGF with beta-galactosidase reporter exhibit an elevated VEGF, localiz
241             Expression of the bacterial beta-galactosidase reporter gene (lacZ) in the vector used fo
242 tion of the intronic CArG region from a beta-galactosidase reporter gene abolished transgene expressi
243 5'UTR clearly decreased expression of a beta-galactosidase reporter in a proportional manner, a delet
244 lly conferred thermoregulation upon the beta-galactosidase reporter in E. coli.
245 ed pCTEN-Cre:R26R mice by crossing R26R beta-galactosidase reporter mice with pCTEN-Cre transgenic mi
246 a premature UAG stop codon located in a beta-galactosidase reporter.
247  splicing, induction of KAR2, PDI1, and beta-galactosidase reporters, and survival of ER stress, but
248                      DNA-functionalized beta-galactosidase retains its ability to catalyze the hydrol
249 S) production and senescence-associated beta-galactosidase (SA-beta-gal) activity but an increase in
250                   Senescence-associated beta-galactosidase (SA-beta-Gal) activity was investigated by
251 n; an increase in senescence-associated beta-galactosidase (SA-beta-Gal) activity, a marker of cellul
252 rked by increased senescence-associated beta-galactosidase (SA-beta-Gal) staining and gammaH2AX-posit
253 lat, enlarged and senescence-associated beta-galactosidase (SA-beta-Gal)-positive cells.
254  (DDR) signaling, senescence-associated beta-galactosidase (SA-betagal) activity, increased expressio
255 ers p21(CIP1/WAF1), senescence-associated ss-galactosidase (SA-ss-gal), and p16(INK4a) were increased
256 d found that only senescence-associated beta-galactosidase (SAbetagal) activity is specifically enric
257                                 An anti-beta-galactosidase scFv:MOG fusion protein (scFv GL117:MOG) s
258 als are needed to confirm this result, alpha-galactosidase seems to be a safe, well tolerated and eff
259  (addition of enzymatic preparation and beta-galactosidase separately and dry ice addition) may affec
260 ignment of CpGAL with other known plant beta-galactosidase showed high amino acid sequence homology.
261                                        alpha-galactosidase significantly reduced global distress (p =
262 ation of DC before adoptive transfer of beta-galactosidase-specific T cells dramatically increased se
263  was evaluated by senescence-associated beta-Galactosidase staining and by Western blot analysis of p
264 ver tissue and by senescence-associated beta-galactosidase staining in a culture-based model of insul
265   KLK4 protein levels in rat enamel and beta-galactosidase staining in LacZ-C57BL/6-Klk4 (+/LacZ) mou
266                                      By beta-galactosidase staining, a subpopulation of Cdc42-null NC
267 ce, determined by senescence-associated beta-galactosidase staining, was obviously attenuated by p38-
268                                      By beta-galactosidase staining, we demonstrated that Mig-6 was u
269 senescence activation, as indicated by beta--galactosidase staining.
270  quantification of senescence-activated beta-galactosidase staining.
271 fundi harbors a model polyextremophilic beta-galactosidase that functions in cold, hypersaline condit
272 7 is an exo-acting 3,6-anhydro-alpha-(1,3)-L-galactosidase that removes the 3,6-anhydrogalactose from
273 te based on a substituted enzyme (G794A-beta-galactosidase) that traps allolactose.
274 e Cre-loxP system allowed to direct the beta-galactosidase to proximal dendrites, and in particular t
275 s exoglycosidases, one of which is BgaC beta-galactosidase, to deglycosidate host surface glycolconju
276 th reduced co-localisation of the viral beta-galactosidase transgene with MAdCAM-1+ sinus-lining endo
277                           We found that beta-galactosidase translocation is driven only by the negati
278 sed approach to quantify pep-1-mediated beta-galactosidase translocation.
279 02 in the LHb previously transfected with ss-galactosidase under control of the FosB promoter.
280 Daun02 in the dlBST previously expressing ss-galactosidase under control of the FosB/DeltaFosB promot
281 6/lacZ reporter mouse strain expressing beta-galactosidase under the control of the Mig-6 gene promot
282  we used RRas2-knockout mice expressing beta-galactosidase under the regulation of the endogenous RRa
283 , as evidenced by senescence-associated beta-galactosidase upregulation, decreased self-renewal poten
284 hydrolysis by the immobilized K. lactis beta-galactosidase using genipin as a crosslinker was 87%.
285 wn mRNA of a selected chromosomal gene (beta-galactosidase) using an artificial miniCRISPR locus.
286 aximum GOS concentration with K. lactis beta-galactosidase was achieved in 1 and 5h at 40 and 4 degre
287                              Initially, beta-galactosidase was employed as a detectable model for BT
288     Expression of senescence-associated beta-galactosidase was greatly induced in hepatocytes exposed
289                                  Cicer alpha-galactosidase was immobilized onto functionalized graphe
290                        Escherichia coli beta-galactosidase was incubated in the presence of the slow-
291 gle enzyme molecule of Escherichia coli beta-galactosidase was measured using a capillary electrophor
292        Finally, the expression level of beta-galactosidase was significantly higher when point mutati
293 ke growth factor binding protein 7, and beta-galactosidase were able to distinguish the severe neurol
294                        Here we focus on beta-galactosidase, which is overexpressed in primary ovarian
295 wn of some lactose and the provision of beta-galactosidase, which remains active in the gastrointesti
296 alytic ability of the hydrolytic enzyme beta-galactosidase, which serves as the protein core, despite
297  cells with HHV-8 induces expression of beta-galactosidase, which was used to determine TCID50 levels
298    Among patients with suitable mutant alpha-galactosidase who received migalastat for up to 24 month
299 ect enzyme activity for the reaction of beta-galactosidase with p-aminophenyl-galactopyranoside (PAPG
300      Kanzi apples had lower activity of beta-galactosidase, with no decline in the extent of branchin

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top